ライフサイエンスコーパス: very low birth weight infant

1 of other morbid conditions in full-term and very low birth weight infants.

2 sk factor for intraventricular hemorrhage in very low birth weight infants.

3 y protein intake may improve growth in these very low birth weight infants.

4 and aggressive administration of protein to very low birth weight infants.

5 al palsy in a geographically based cohort of very low birth weight infants.

6 easure clinical risk and illness severity in very low birth-weight infants.

7 such facilities might reduce mortality among very-low-birth-weight infants.

8 ious levels of care and different volumes of very-low-birth-weight infants.

9 gulase-negative staphylococcal infections in very-low-birth-weight infants.

10 ncommon but potentially lethal problem among very-low-birth-weight infants.

11 rcent of low-birth-weight and 4.3 percent of very-low-birth-weight infants.

12 our weeks of age in 371 ventilator-dependent very-low-birth-weight infants (501 to 1500 g) who had re

13 The majority of very low birth weight infants (52%) were discharged on f

14 Diminution in risk was greater for very low birth weight infants, amounting to a sevenfold

15 liver disease, necrotizing enterocolitis in very low birth weight infants, and hepatic encephalopath

16 Very low birth weight infants are at high risk, particul

17 dysplasia (BPD) is a chronic lung disease of very low birth weight infants, associated with oxygen th

18 r, double-blind randomized clinical trial in very low-birth-weight infants (birth weight <1500 g) adm

19 ree days of life and compared them with 7606 very-low-birth-weight infants born at centers in the net

20 We compared a cohort of 242 survivors among very-low-birth-weight infants born between 1977 and 1979

21 The neonatal mortality rate among all very-low-birth-weight infants decreased 17 percent, from

22 among black infants, the mortality rate for very-low-birth-weight infants did not change significant

23 eding support by nurses have higher rates of very low birth weight infants discharged home on human m

24 evel between the dependent variable (rate of very low birth weight infants discharged on "any human m

25 e nature of dermal structure and function in very low birth weight infants, evidence of mechanical fr

26 Most conventionally managed very low birth weight infants experience postnatal growt

27 occurring within 72 hours after birth) among very-low-birth-weight infants have changed in recent yea

28 Very-low-birth-weight infants have high levels of duoden

29 possible after birth at 2.5-3.0 g/kg/day in very low birth weight infants; however, there are no lon

30 proportionate number of low-birth-weight and very-low-birth-weight infants in the United States, in p

31 Very low-birth-weight infant infection rates were 16.4%

32 Major surgery in very low-birth-weight infants is independently associate

33 al population, but levels of vaccination for very low-birth-weight infants lag slightly behind.

34 (2500-3999 g), while the admission rate for very low-birth-weight infants (<1500 g) was 844.1 per 10

35 th a high level of care and a high volume of very-low-birth-weight infants (more than 100 per year),

36 ver the past 2 decades on the development of very-low-birth-weight infants' oral feeding skills.

37 effective use of preventive therapies in the very low birth weight infant population.

38 oid (GC) therapy, while approximately 19% of very low birth weight infants receive postnatal GC thera

39 e risk of necrotizing enterocolitis (NEC) in very low birth weight infants receiving indomethacin (IN

40 life yielded similar short-term outcomes in very low-birth-weight infants regarding safety and effic

41 ctice did not improve outcomes in premature, very low-birth-weight infants requiring a transfusion.

42 cently provided reference range for uNGAL in very low birth weight infants shows that normative value

43 Chinese women were less likely to have very low birth weight infants than were whites.

44 We studied 5447 very-low-birth-weight infants (those weighing between 40

45 Very-low-birth-weight infants (those weighing less than

46 Mortality rates among very-low-birth-weight infants varied according to both t

47 Mortality among very-low-birth-weight infants was lowest for deliveries

48 assess neonatal mortality rates among 48,237 very-low-birth-weight infants who were born in Californi

49 compassionate use of tin mesoporphyrin in a very low birth weight infant with intrauterine growth re

50 exists regarding the best method of managing very low birth weight infants with PDA and whether to em

51 Prevention of IC has become a major focus in very low birth weight infants, with fluconazole increasi

52 lation in terms of the pulmonary outcome for very-low-birth-weight infants without an increase in the